A5091976745- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Coronary Interventions and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
National Medical Research Center of Cardiology
2023-2025
Objective. To evaluate the efficacy and safety of transcatheter aortic valve implantation (TAVI) in patients with severe coronary artery (CA) lesions without prior myocardial revascularization. Material methods. A retrospective study included 270 who underwent TIA 2016-2021. In some (n=200, group 1), TAVI was performed after preliminary percutaneous intervention (PCI), other cases (n=70, 2) — PCI. Propensity score matching performed. Finally, we distinguished 2 groups by 68 patients. These...
Introduction . Perioperative bleeding is a potentially life-threatening complication of surgical intervention. The incidence perioperative during transcatheter aortic valve implantation (TAVI) reaches 6%. An increased risk noted in patients requiring constant antiplatelet therapy, which includes with concomitant coronary artery disease (CAD). Aim study factors bleeding, require blood transfusion candidates for TAVI CAD. Materials and methods A retrospective study. CAD who underwent from 2016...
Transcatheter aortic valve implantation (TAVI) is commonly accepted method of treatment stenosis in most patients with currently increasing number TAVI procedures. Patients after frequently have indications for percutaneous coronary intervention (PCI) that might be technically challenging due to the presence transcatheter valve. Compromising ostia involves such issues as design prosthesis and its position root respect commissures native Since commissural alignment can mitigate risk...